Tests for infection and resistance in invasive fusarium
Part of Infections, Skin clinical trials.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a doctor’s suspicion of a serious fusarium fungal infection, based on a blood culture, a skin biopsy, or a cornea sample (for eye infection).
- A lab fungal culture has been done on that taken sample.
- Your sample results can be used for this research because you were told about the study and did not object.
- The study is for invasive fusarium infections—not for superficial skin nail or mild forms like toenail fungus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study looks at how well antifungal medicines work against different fungi and how fungi become resistant. By joining, you may help doctors understand your infection and improve future treatments.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This trial tests a new way to find infections (using a test called mNGS) that may be quicker and more accurate than standard tests. It is for people with blood cancers who show signs of a possible fungal infection, like fever or abnormal lung scans.
This trial checks whether a PET-CT scan using a small amount of tracer (FDG) can help doctors better identify invasive fungal infections inside the body. It may be useful for guiding diagnosis when standard information is unclear.
Hear when a new Fusariosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.